These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3492939)

  • 1. Inhibition of natural killer cell activity by antigen-antibody complexes.
    Pedersen BK; Thomsen BS; Nielsen H
    Allergy; 1986 Nov; 41(8):568-74. PubMed ID: 3492939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell activity in Sjögren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes.
    Struyf NJ; Snoeck HW; Bridts CH; De Clerck LS; Stevens WJ
    Ann Rheum Dis; 1990 Sep; 49(9):690-3. PubMed ID: 1700674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the in vitro effect of triethylphosphine gold (auranofin) on human NK cell activity.
    Pedersen BK; Abom B
    Clin Exp Rheumatol; 1986; 4(3):249-53. PubMed ID: 3490341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of IgG and IgM receptor triggering on human natural killer cell cytotoxicity measured on the level of the single effector cell.
    Merrill JE; Ullberg M; Jondal M
    Eur J Immunol; 1981 Jul; 11(7):536-41. PubMed ID: 7286062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chloroquine, mefloquine and quinine on natural killer cell activity in vitro. An analysis of the inhibitory mechanism.
    Pedersen BK; Bygbjerg IC; Theander TG; Andersen BJ
    Allergy; 1986 Sep; 41(7):537-42. PubMed ID: 2431633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cell in systemic lupus erythematosus. Defects in effector lytic activity and response to interferon and interferon inducers.
    Sibbitt WL; Mathews PM; Bankhurst AD
    J Clin Invest; 1983 May; 71(5):1230-9. PubMed ID: 6853711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human natural killer cells limit replication of herpes simplex virus type 1 in vitro.
    Fitzgerald PA; Mendelsohn M; Lopez C
    J Immunol; 1985 Apr; 134(4):2666-72. PubMed ID: 2982949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of in vitro porcine natural killer cell activity by recombinant interleukin-1 alpha, interleukin-2 and interleukin-4.
    Knoblock KF; Canning PC
    Immunology; 1992 Jun; 76(2):299-304. PubMed ID: 1634252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of ongoing human immunoglobulin synthesis by natural killer cells.
    Kimata H; Shanahan F; Brogan M; Targan S; Saxon A
    Cell Immunol; 1987 Jun; 107(1):74-88. PubMed ID: 3495349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human natural killer cell activity by Legionella pneumophila protease.
    Rechnitzer C; Diamant M; Pedersen BK
    Eur J Clin Microbiol Infect Dis; 1989 Nov; 8(11):989-92. PubMed ID: 2513201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CD16 (Fc receptor III) and interleukin-2 in the reactivation of natural killer cells after inhibitory target cell contact.
    Heiskala M; Ståhls A; Seppälä I; Timonen T
    Nat Immun Cell Growth Regul; 1991; 10(5):265-77. PubMed ID: 1836835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of interferon-induced NK cells by interleukin 2 and cAMP.
    Chun M; Hoffmann MK
    Lymphokine Res; 1982; 1(4):91-8. PubMed ID: 6097776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation of natural killer activity in children with acute lymphoblastic leukaemia.
    Jermy A; Jennings R; Lilleyman JS; Rees RC
    Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1371-7. PubMed ID: 3500050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on natural, antibody-dependent, and interleukin-2-activated killer-cell activity of a patient with mucolipidosis III as a test of the mannose-6-phosphate lytic acceptor hypothesis.
    Werkmeister JA; Pross HF
    J Clin Immunol; 1985 Jul; 5(4):228-38. PubMed ID: 2931446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of normal natural killer cytotoxicity by sera from hemophilic patients.
    Vulcano M; Olabuenaga SE; Galassi N; Felippo M; Perez Bianco R; de Bracco MM
    Immunol Lett; 1993 May; 36(2):153-9. PubMed ID: 8349311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK and T cell subsets regulate antibody production by human in vivo antigen-induced lymphoblastoid B cells.
    Brieva JA; Targan S; Stevens RH
    J Immunol; 1984 Feb; 132(2):611-5. PubMed ID: 6228592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural cytotoxicity and serum blocking in malignant cervical neoplasia.
    Pillai MR; Balaram P; Abraham T; Padmanabhan TK; Nair MK
    Am J Reprod Immunol Microbiol; 1988 Apr; 16(4):159-62. PubMed ID: 3421407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural cytotoxicity in systemic lupus erythematosus: mechanisms of suppression by inhibitory serum factors.
    Sibbitt WL; Froelich CJ; Bankhurst AD
    Clin Exp Immunol; 1983 Aug; 53(2):363-70. PubMed ID: 6883808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysis of pig endothelium by IL-2 activated human natural killer cells is inhibited by swine and human major histocompatibility complex (MHC) class I gene products.
    Itescu S; Artrip JH; Kwiatkowski PA; Wang SF; Minanov OP; Morgenthau AS; Michler RE
    Ann Transplant; 1997; 2(1):14-20. PubMed ID: 9869836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of interferons and interleukin 2 on natural killing of cytomegalovirus-infected fibroblasts.
    Bandyopadhyay S; Miller DS; Matsumoto-Kobayashi M; Clark SC; Starr SE
    Clin Exp Immunol; 1987 Feb; 67(2):372-82. PubMed ID: 2440628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.